Desar, I.M.E. et al. 2010. Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours. Acta Oncologica. 49, 1 (Jan. 2010), 113–116. DOI:https://doi.org/10.3109/02841860903104152.